L. Guijarro

Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials.

Laura M Sanz, L. Ballell-Pages, M. Blackman, 2015, Journal of medicinal chemistry.

Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions

Robert H Bates, M. Vieth, P. Hipskind, 2022, ACS infectious diseases.

Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB

A. Korkegian, K. Read, P. Hipskind, 2018, Journal of medicinal chemistry.

Mycobacterium tuberculosis Decaprenylphosphoryl-β-D-ribose Oxidase inhibitors: expeditious reconstruction of sub-optimal hits into a series with potent in vivo activity.

I. Wall, G. Burley, M. Cacho, 2020, Journal of medicinal chemistry.

Optimization of hydantoins as potent antimycobacterial decaprenylphosphoryl-β-D-ribose oxidase (DprE1) inhibitors.

Robert H Bates, Fraser Cunningham, P. Van der Veken, 2020, Journal of medicinal chemistry.

Acceleration of infectious disease drug discovery and development using a humanized model of drug metabolism

Frederick R. C. Simeons, K. Read, Jennifer Riley, 2024, Proceedings of the National Academy of Sciences of the United States of America.